RGEN - Repligen Corp Expected Profit

Graphic logo of Repligen Corporation (RGEN)

Global logistics risks and export restrictions are putting pressure on Repligen Corporation (RGEN) technology deliveries. The organization's future profit trend visualizes the revenue consensus, where 0.17 expresses today's metric value. An active M&A strategy offsets the industry downturn, yet stringent bioprocessing regulatory standards create high barriers, making it difficult for clients to switch suppliers due to the high cost of process recertification.

RGEN: Repligen Inc. Company Profit Forecast 07/04/2022 - 11/16/2026

Metric breakdowns and analytics for Repligen Inc. (RGEN)

- market capitalization statistics:
General company analysis:Repligen
Finished products of Repligen Corp.

Repligen Corporation (RGEN) strategic alliances in bioprocessing and the acquisition of filtration startups are building long-term revenue scaling potential. Analyzing the company's target profit levels, investors assess the consensus net income forecast, which offsets reporting volatility and allows for the determination of business maturity through the stability of financial expectations, revealing hidden risks of growth deceleration.

Competitor analysis for Repligen Corporation

Expected Profit Tempus AI|Projected Future Earnings Qiagen|Projected Future Earnings IONS|Company Profit Forecast Avidity Biosciences|Expected Profit CRISPR Therapeutics Corp CRSP|WGS: Net Profit Forecast|ultragenyx.com - Projected Future Earnings|Beam Therapeutics - Future Net Profit|SRPT: Projected Future Earnings|TWST (Twist Bio) - Expected Profit|TXG (10xgenomics.com) - Projected Future Earnings|Projected Future Earnings Intellia Therapeutics, Inc.|Projected Future Earnings STOK|Company Profit Forecast BioLife Solutions Inc|Expected Profit Wave Pharma WVE|Projected Future Earnings Maze Therapeutics Corp MAZE|SION - Expected Profit|Prime Medicine, Inc. (PRME) - Future Profit|TSHA (Taysha Gene Therapies, Inc.) - Future Profit|QURE - Company Profit Forecast|MGTX (MeiraGTx Holdings plc) - Projected Future Earnings|Future Profit REGENXBIO Inc. (RGNX)|Expected Profit Solid Biosciences (SLDB)|ocugen.com (OCGN) - Projected Net Profit|Projected Future Earnings PACB (PacBio Corp)|Expected Net Income BNTC|DSGN: Future Profit|RCKT - Projected Future Earnings|Expected Net Income 4D Molecular Corp FDMT|Future Profit Lexeo|Expected Profit Korro Bio Inc.|Net Profit Forecast EDIT (Editas Medicine)|Expected Profit Silence Therapeutics Corp (SLN)|PRQR (ProQR) - Expected Net Income|Projected Future Earnings CDXS (Codexis, Inc.)|Company Profit Forecast sangamo.com (SGMO)|nautilus.bio - Projected Future Earnings|Metagenomi (MGX) - Future Profit|DTIL: Projected Future Earnings|Expected Net Profit Generation Bio Co (GBIO)|BOLD (Boundless Bio) - Projected Future Earnings|Future Profit Exicure (XCUR)|Expected Profit Celsion Corporation (IMNN)|PHIO - Expected Net Profit|Mustang Bio Inc - Future Profit|Projected Future Earnings transcodetherapeutics.com RNAZ|Bionano Genomics Inc. - Projected Future Earnings|APDN (Applied DNA Sciences) - Net Profit Forecast|BLUE (bluebirdbio.com) - Future Profit|Net Profit Forecast IPA|OMGA (omegatherapeutics.com) - Projected Future Earnings|Singular Genomics Systems Inc (OMIC) - Company Profit Forecast|Projected Future Earnings RGLS|Company Profit Forecast Syros Pharmaceuticals, Inc.|Expected Profit Telesis Bio Inc. TBIO|Future Net Profit TCON (TRACON Pharmaceuticals Inc.)|Unity Bio - Projected Future Earnings